Clinical Trial Update: Efficacy and Safety Study of QLG1080 in Patients With Hormone-sensitive Advanced Prostate Cancer [Phase 3]

View source ↗

Summary

Clinical trial update for a Phase 3 study of QLG1080 in hormone-sensitive advanced prostate cancer; trial status listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• QLG1080

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Prostate Cancer | Phase 3 | Status: NOT_YET_RECRUITING